No I don't sorry. Generally it is around 30% cheaper than usual. Healey are also very good at attracting attracting grants from various foundations to assist small companies.The fact that some of their costs were covered was a significant benefit for the smaller companies in the HEALEY trial. Prilenia, for example, had six employees at the time it applied to join the trial. “The good news was they paid for the drug, so we didn’t have to raise money for [that],” CEO Michael Hayden told BioSpace. The infrastructure build and support were also partially funded by several foundations, Cudkowicz said.
“I’m grateful. Without HEALEY, we would never have done this trial,” Hayden said. “We didn’t have the money.”
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.005(3.03%) |
Mkt cap ! $83.69M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.0¢ | 16.5¢ | $31.76K | 188.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 29214 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 59381 | 1 |
View Market Depth
| Last trade - 16.10pm 17/06/2025 (20 minute delay) ? |
| NUZ (ASX) Chart |